Coronavirus survivors’ plasma used in NHS treatment trials

The NHS has begun trials to find out if using blood plasma from patients who’ve recovered from coronavirus could help treat people who’ve become critically ill.

As scientists around the world scramble to find a treatment – in the United States, the antiviral drug remdesivir, used to treat ebola, has just been authorised for emergency use on Covid patients.

With the prospect of a vaccine still a very long way away – could finding effective treatments come sooner?